Auron Therapeutics is a medtech company specializing in cancer formation research. It develops a machine learning platform that integrates multi-omic datasets from primary human tissue samples to enable a systems-biology understanding of normal cellular differentiation. In addition, the platform allows targeting dysregulated differentiation and cellular plasticity mechanisms in well-defined patient populations.